Open Offer Draft filed with SEBI for Bliss GVS Pharma acquisition

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF Explain this filing

ANURAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹1267.40

prior close

₹1255.40

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.1%+1.4% vs market

Specialty Chemicals peers, median of 91sector-1.0%+1.2% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Smallcap 250 and 1.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+1.1

15m

+1.3

30m

+1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2-1.1+1.4-1.0+1.2

Next day

-1.1-2.0+0.9-2.2+1.1

-1.9+0.6-2.5-0.1-1.8

-0.9+1.9-2.8+1.6-2.5

-0.9+2.3-3.2+1.9-2.8

+2.5+3.1-0.6+1.9+0.6

+1.3+4.3-3.1+2.7-1.5

15d

+0.5+5.9-5.4+2.4-1.9

-0.1+6.7-6.9+2.8-3.0

-4.4+8.1-12.4+5.9-10.3

-2.7+8.6-11.3+9.8-12.5

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 91Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Manager SBI Capital Markets filed the Draft Letter of Offer with SEBI for Anupam Rasayan's mandatory open offer to buy up to 2.77 crore shares (26 percent stake) of Bliss GVS Pharma at Rs 299 per share. Total deal value is up to about Rs 829 crore assuming full acceptance. The offer opens on July 16, 2026 and closes on July 29, 2026. The offer follows a Share Purchase Agreement signed with existing promoters and select shareholders of Bliss GVS Pharma.

Likely market impact

Anupam Rasayan is acquiring up to 26 percent in Bliss GVS Pharma for about Rs 829 crore, signaling entry into pharma. Bliss GVS public shareholders may tender shares at Rs 299.